JOSÉ LUIS
LOBO BERISTAIN
Investigador hasta 2023
Universitat Autònoma de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (14)
2024
-
Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine
European Journal of Clinical Investigation
2022
-
Cancer Histology and Natural History of Patients with Lung Cancer and Venous Thromboembolism
Cancers, Vol. 14, Núm. 17
-
Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism
Internal and Emergency Medicine, Vol. 17, Núm. 3, pp. 725-734
-
Predictors of use of direct oral anticoagulants in patients with venous thromboembolism: Findings from the Registro Informatizado Enfermedad Tromboembólica registry
Frontiers in Medicine, Vol. 9
2021
-
Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism
European Respiratory Journal, Vol. 58, Núm. 1
2020
-
Correction to: Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism (Internal and Emergency Medicine, (2019), 14, 7, (1101-1112), 10.1007/s11739-019-02077-5)
Internal and Emergency Medicine
-
Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project
Clinical and Applied Thrombosis/Hemostasis, Vol. 26
2019
-
Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years
Scientific Reports, Vol. 9, Núm. 1
-
Correction to: Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism (Internal and Emergency Medicine, (2019), 14, 7, (1101-1112), 10.1007/s11739-019-02077-5)
Internal and Emergency Medicine
-
Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry
Orphanet Journal of Rare Diseases, Vol. 14, Núm. 1
-
Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism
Internal and Emergency Medicine
2015
-
A founder EIF2AK4 mutation causes an aggressive form of pulmonary arterial hypertension in Iberian Gypsies
Clinical Genetics, Vol. 88, Núm. 6, pp. 579-583
-
Fondaparinux in the initial and long-term treatment of venous thromboembolism
Thrombosis Research, Vol. 135, Núm. 2, pp. 311-317